The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses

Author： Machado Márcio   Iskedjian Michael  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.11, 2007-01, pp. : 979-990

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients

By Ya-Chen Tina Shih   Bekele Nebiyou B.   Xu Ying  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 843-862

Adis International

Access to resources Recommend Favorite

The safety of serotonin–noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 143-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Budget-Impact Analyses: A Critical Review of Published Studies

By Orlewska Ewa  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 807-827

Adis International

Access to resources Recommend Favorite

A Comparison of the Direct Costs and Cost Effectiveness of Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions

By Sullivan Patrick W.  

CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. : 911-932

Adis International

Access to resources Recommend Favorite

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite